Position in EXEL
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$16,488,515
+$3,094,140 QoQ
Shares Held
303,042
-3.0% QoQ
Ownership
0.122%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#102
of 754 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 75%
Shared 0%
None 25%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CAPTRUST FINANCIAL ADVISORS holds $167,363,866 across 124 Biotechnology names. EXEL ranks #4 (9.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
36,464 | $22,736,762 | |
| 2 | RPRX |
Royalty Pharma plc
|
337,298 | $18,912,298 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
35,471 | $17,619,509 | |
| 4 | EXEL |
Exelixis, Inc.
This page
|
303,042 | $16,488,515 | |
| 5 | LGND |
Ligand Pharmaceuticals Inc
|
34,607 | $10,938,926 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
125,946 | $9,857,793 | |
| 7 | CELC |
Celcuity Inc.
|
71,445 | $7,474,575 | |
| 8 | INCY |
Incyte Corp
|
50,301 | $5,702,121 |
All Filings in EXEL
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $16,488,515 | 303,042 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $13,394,375 | 312,296 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $4,343,509 | 99,099 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $3,109,600 | 75,293 | Shares | Sole | 2025-11-19 | |
| 2025-06-30 | $3,118,483 | 70,746 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $2,356,123 | 63,817 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,846,718 | 55,457 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $919,408 | 35,430 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $765,373 | 34,062 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $768,994 | 32,406 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $1,246,256 | 51,949 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $916,061 | 41,925 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $360,949 | 18,888 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $330,610 | 17,033 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $219,010 | 13,654 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $247,210 | 15,766 | Shares | Sole | 2022-11-16 | |
| 2022-06-30 | $122,733 | 5,895 | Shares | Sole | 2022-08-23 | |
| 2022-03-31 | $234,702 | 10,353 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $191,958 | 10,501 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $198,293 | 9,380 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $270,439 | 14,843 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $475,293 | 21,040 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $179,606 | 8,949 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $208,656 | 8,534 | Shares | Sole | 2020-11-17 | |
| 2020-06-30 | $157,728 | 6,644 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $80,073 | 4,650 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||